Are you Dr. Reeves?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 115 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
8260 Gladiolus Dr
Fort Myers, FL 33908Phone+1 239-437-5755Fax+1 239-437-5776
Summary
- Dr. James Reeves Jr., MD is an oncologist in Fort Myers, Florida. He is currently licensed to practice medicine in Florida, Louisiana, and Alabama. He is affiliated with Lee Memorial Hospital and Cape Coral Hospital.
Education & Training
University of Alabama Medical CenterFellowship, Hematology and Medical Oncology, 1985 - 1988- University of Alabama Medical CenterResidency, Internal Medicine, 1982 - 1985
Louisiana State University School of Medicine in New OrleansClass of 1982
Certifications & Licensure
FL State Medical License 1988 - 2025
AL State Medical License Active through 1988
LA State Medical License 1982 - 1984- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011-2014
Clinical Trials
- A Phase 2 Study of ASONEP™ to Treat Unresectable and Refractory Renal Cell Carcinoma Start of enrollment: 2013 Feb 01
- Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma Start of enrollment: 2013 Jul 12
- Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA Start of enrollment: 2013 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 12 citationsTumor-Specific and Tumor-Agnostic Molecular Signatures Associated With Response to Immune Checkpoint InhibitorsDaniel Schlauch, Xiaotong Fu, Suzanne F. Jones, Howard A. Burris, David R. Spigel
JCO Precision Oncology. 2021-10-22 - 844 citationsClinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinomaDavid F. McDermott, Mahrukh Huseni, Michael B. Atkins, Robert J. Motzer, Brian I. Rini
Nature Medicine. 2018-06-01 - 25 citationsTreatment With Adjuvant Abemaciclib Plus Endocrine Therapy in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy: A Prespecified Analysi...Miguel Martin, Roberto Hegg, Sung-Bae Kim, Michael Schenker, Daniela Grecea
JAMA Oncology. 2022-08-01
